Royal Bank of Canada’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$116K Buy
3,034
+1,826
+151% +$57.8K ﹤0.01% 5040
2025
Q4
$26K Sell
1,208
-19,203
-94% -$399K ﹤0.01% 5888
2025
Q3
$438K Buy
20,411
+2,334
+13% +$52.3K ﹤0.01% 4591
2025
Q2
$464K Buy
18,077
+17,764
+5,675% +$520K ﹤0.01% 4524
2025
Q1
$11K Sell
313
-421
-57% -$14.5K ﹤0.01% 6115
2024
Q4
$22K Sell
734
-1,916
-72% -$63.7K ﹤0.01% 6068
2024
Q3
$100K Buy
2,650
+1,257
+90% +$48.5K ﹤0.01% 5341
2024
Q2
$55K Buy
1,393
+116
+9% +$3.75K ﹤0.01% 5598
2024
Q1
$43K Sell
1,277
-2,603
-67% -$87.5K ﹤0.01% 5599
2023
Q4
$129K Buy
3,880
+2,034
+110% +$65.6K ﹤0.01% 5451
2023
Q3
$58K Buy
1,846
+156
+9% +$4.91K ﹤0.01% 5702
2023
Q2
$53K Buy
1,690
+560
+50% +$18.1K ﹤0.01% 5751
2023
Q1
$37K Sell
1,130
-2,214
-66% -$72.5K ﹤0.01% 5772
2022
Q4
$108K Buy
3,344
+3,020
+932% +$103K ﹤0.01% 5387
2022
Q3
$12K Buy
324
+156
+93% +$6.48K ﹤0.01% 6332
2022
Q2
$7K Sell
168
-4,647
-97% -$226K ﹤0.01% 6503
2022
Q1
$278K Sell
4,815
-4,165
-46% -$228K ﹤0.01% 4786
2021
Q4
$528K Buy
8,980
+1,156
+15% +$70.2K ﹤0.01% 4396
2021
Q3
$475K Sell
7,824
-538
-6% -$31.5K ﹤0.01% 4411
2021
Q2
$502K Buy
8,362
+118
+1% +$5.91K ﹤0.01% 4271
2021
Q1
$388K Buy
8,244
+7,951
+2,714% +$327K ﹤0.01% 4396
2020
Q4
$11K Buy
293
+166
+131% +$5.47K ﹤0.01% 6325
2020
Q3
$4K Buy
127
+10
+9% +$423 ﹤0.01% 6163
2020
Q2
$5K Sell
117
-38
-25% -$1.94K ﹤0.01% 6020
2020
Q1
$7K Sell
155
-356
-70% -$16.1K ﹤0.01% 5928
2019
Q4
$21K Buy
511
+411
+411% +$16.8K ﹤0.01% 5827
2019
Q3
$4K Buy
+100
New +$4.21K ﹤0.01% 6082
2019
Q1
Sell
-222
Closed -$8K 6789
2018
Q4
$8K Sell
222
-57
-20% -$2.23K ﹤0.01% 5978
2018
Q3
$9K Buy
279
+173
+163% +$5.06K ﹤0.01% 6013
2018
Q2
$3K Buy
+106
New +$2.95K ﹤0.01% 6149
2017
Q3
Sell
-116
Closed -$3K 6698
2017
Q2
$3K Buy
+116
New +$2.69K ﹤0.01% 6175
2017
Q1
Sell
-791
Closed -$18K 6597
2016
Q4
$18K Buy
791
+591
+296% +$14.3K ﹤0.01% 5824
2016
Q3
$5K Sell
200
-234
-54% -$5.23K ﹤0.01% 5953
2016
Q2
$9K Buy
434
+200
+85% +$6.3K ﹤0.01% 5769
2016
Q1
$8K Buy
234
+203
+655% +$5.37K ﹤0.01% 5791
2015
Q4
$1K Sell
31
-582
-95% -$15.9K ﹤0.01% 6442
2015
Q3
$18K Sell
613
-186
-23% -$6.09K ﹤0.01% 5602
2015
Q2
$34K Buy
+799
New +$37.7K ﹤0.01% 5421

Other funds holding ATEX

Royal Bank of Canada's ATEX Position: Q1 2026 in Review

Royal Bank of Canada increased its Anterix (ATEX) stake by 151% in Q1 2026, buying an estimated $57.8K and bringing the position to 3,034 shares worth $116K. The position accounts for ﹤0.01% of the portfolio, ranked #5040.

Royal Bank of Canada first reported a position in ATEX in Q2 2015 and has held it in 38 quarters since. The position peaked at $528K in Q4 2021. 132 funds tracked by Wall St. Rank hold ATEX as of Q1 2026.

  • Royal Bank of Canada held 3,034 shares of Anterix worth $116K as of Q1 2026.
  • Royal Bank of Canada bought 1,826 Anterix shares in Q1 2026, an estimated $57.8K.
  • Anterix made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #5040 holding.
  • Royal Bank of Canada first reported a position in Anterix in Q2 2015 and has held it in 38 quarters since.
  • Royal Bank of Canada's Anterix position peaked at $528K in Q4 2021.
  • 132 funds tracked by Wall St. Rank held Anterix as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.